Trial intelligence / Profile preview

Effect of citalopram on chest pain in patients with achalasia

2024-517701-81-01Phase 4Completed

Sponsor
Amsterdam University Medical Center
Start
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised, double-blind trial in achalasia comparing Citalopram with Placebo (2 arms). Primary endpoint: Global assessment of chest pain relief. Started Dec 2024; status: completed.

02

Drugs

citalopram
03

Conditions

achalasia

Beyond the preview

Go deeper on 2024-517701-81-01.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2024-517701-81-01.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call